...
首页> 外文期刊>Medicinal Chemistry >Bioassay-guided Isolation of the Antidiabetic Active Principle from Salviamiltiorrhiza and its Stimulatory Effects on Glucose Uptake Using 3T3-L1Adipocytes
【24h】

Bioassay-guided Isolation of the Antidiabetic Active Principle from Salviamiltiorrhiza and its Stimulatory Effects on Glucose Uptake Using 3T3-L1Adipocytes

机译:生物测定指导的丹参中抗糖尿病活性成分的分离及其对使用3T3-L1脂肪细胞摄取葡萄糖的刺激作用

获取原文
           

摘要

Natural products, which reduce hyperglycemia by enhancing the glucose uptake in peripheral tissues, have been considered to be effective for treatment of Type-2 Diabetes Mellitus. Salvia miltiorrhiza (Labiatae), danshen, has been widely used traditional Chinese medicine for the treatment of various cardiovascular and cerebrovascular diseases. In the present study, different extracts of Salvia miltiorrhiza root were investigated for their ability to enhance glucose uptake in differentiated 3T3-L1 adipocytes. An in vitro bioassay guided fractionation approach was adapted to isolate the active principle of Salvia miltiorrhiza using extensive column chromatographic techniques. The structure of active compound was elucidated using various spectroscopic methods (ESI-MS, MALDI-ToF, 1H-NMR, 13C-NMR, COSY, TOCSY, HETCOR) and determined to be magnesium salt of salvianolic acid B (SAB). SAB showed concentration dependent increase in glucose uptake in 3T3-L1 adipocytes. The efficacy of the active principle was also evaluated for its antidiabetic activity in streptozotocin-induced diabetic rats. SAB (25 mg/kg) significantly improved the glucose tolerance in diabetic rats (*p<0.05, ** p<0.01). The SAB treatment group showed significantly lower (*p<0.05) blood glucose levels over 120 min as compared to diabetic control group. Thus, these results suggested that SAB has the potential to be developed as a potential glucose-lowering agent by increasing glucose uptake in peripheral tissues in the treatment of diabetes mellitus.
机译:通过增强外周组织对葡萄糖的吸收来减少高血糖症的天然产品被认为对治疗2型糖尿病有效。丹参丹参(Labiatae)已被广泛用于治疗各种心血管和脑血管疾病的中药。在本研究中,研究了丹参不同提取物增强分化的3T3-L1脂肪细胞摄取葡萄糖的能力。采用广泛的柱色谱技术,采用体外生物测定指导的分馏方法来分离丹参的有效成分。使用各种光谱方法(ESI-MS,MALDI-ToF,1H-NMR,13C-NMR,COSY,TOCSY,HETCOR)阐明活性化合物的结构,并确定其为丹酚酸B(SAB)的镁盐。 SAB显示3T3-L1脂肪细胞中葡萄糖摄取的浓度依赖性增加。还评估了该活性成分在链脲佐菌素诱导的糖尿病大鼠中的抗糖尿病活性。 SAB(25 mg / kg)显着改善了糖尿病大鼠的葡萄糖耐量(* p <0.05,** p <0.01)。与糖尿病对照组相比,SAB治疗组在120分钟内的血糖水平显着降低(* p <0.05)。因此,这些结果表明,在糖尿病的治疗中,通过增加周围组织中的葡萄糖摄取,SAB具有被开发为潜在的降糖药的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号